Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00315_DB00353> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00315_DB00353 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00353 label "DDI between Zolmitriptan and Methylergometrine - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, methylergonovine, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. [drugbank_resource:DB00315_DB00353]" assertion.
- drugbank_resource:DB00315_DB00353 identifier "drugbank_resource:DB00315_DB00353" assertion.
- drugbank_resource:DB00315_DB00353 title "DDI between Zolmitriptan and Methylergometrine - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, methylergonovine, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated." assertion.